Obesity: A Translational Outlook from Basic Molecular Mechanisms to Clinical Management

LIVEDHPAMAFace to Face

Add to Calendar Obesity: A Translational Outlook from Basic Molecular Mechanisms to Clinical Management 5/13/2022 3:45:00 PM 5/14/2022 6:15:00 PM Asia/Riyadh For More Details: https://wcmq.cloud-cme.com/course/courseoverview?EID=2258 Description: Obesity is highly prevalent worldwide. There has been significant advances in our understanding of obesity and its management. This 2-day activity on obesity aims to provide an excellent overview of the basic science related to obesity along with the evaluation and management of patients with obesity. Weill Cornell Medicine-Qatar (Lecture Hall 4) false MM/DD/YYYY


Date & Location
Friday, May 13, 2022, 3:45 PM - Saturday, May 14, 2022, 6:15 PM, Weill Cornell Medicine-Qatar (Lecture Hall 4)

Overview
Obesity is highly prevalent worldwide. There has been significant advances in our understanding of obesity and its management. This 2-day activity on obesity aims to provide an excellent overview of the basic science related to obesity along with the evaluation and management of patients with obesity.

Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Students

Overall Learning Objective
  1. 1- Demonstrate an understanding of the complexity of development and treatment of obesity
  2. 2- Recognize the health risks of obesity and the benefits associated with weight loss
  3. 3- Formulate a treatment plan for obesity that includes lifestyle modifications and advanced approaches e.g. pharmacotherapy and bariatric surgeries
  4. 4- Describe the role of social media in patients’ engagement and satisfaction.

Registration

Early bird registration fees until May 10, 2022 - $21 or QAR 75 
Registration fees starting  May 11, 2022 - $41 or QAR 150

Changes or Cancellations

Name changes or substitutions are not permitted.
All cancellation and refund requests must be made in writing and submitted via email to [email protected].
For a full refund of the registration fee, the cancellation request must be received at least 7 days prior to the session. No refund will be offered for cancellation request thereafter.
We will attempt to process the refund within 30 days of receiving any cancellation request.
Weill Cornell Medicine-Qatar reserves the right to cancel the course. In the event of a cancellation, fee deposit will be returned, but we will not be responsible for any other expenses including restricted or non-refundable airfare or hotel deposits.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to  [email protected].


Accreditation

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Department of Healthcare Professions (DHP) of the Ministry of Public Health.

 

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 5 hours. 

 

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

 

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health's Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

 

Course Directors: Nasrin Mesaeli, PhD, Tariq Chukir, MD have no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

 

Course Faculty: Tariq Chukir, MD, Nasrin Mesaeli, PhD, Shaza Zaghloul, PhD, Rewa Refai, RD, Bassem Safadi, MD, Hiba Bawadi, Nayef Mazloum, PhD, have no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

 

Scientific Planning Committee: Phyllis Muffuh Navti, DHSci, Nayef Mazloum, PhD, Nicola Lategan, RT, Mark Santos, RN, Constantina Dalassou, DDS, Tariq Chukir, MD, Nasrin Mesaeli, PhD

 

Course Faculty: Sonali Malhotra, MD, has disclosed the following: Employee - Rhythm Pharmaceuticals, Consultant - Novo Nordisk; WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Morgan Dickison, RD, has disclosed the following: Independant Contractor - Intellihealth Inc; WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products. 

Shahrad Taheri, MD, has disclosed the following: Advisor – Novo Nordisk;  WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products. 


 Administrative Contact: Ameena Abdul Rahim, MSc has no relevant financial relationship to disclose; WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

 

ICR: Tariq Chukir, MD has no relevant financial relationship to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

 

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.